Richard Fengl

Richard Fengl, Ph.D., has a diverse work experience in the pharmaceutical industry. Richard currently holds the role of Executive Director, Business Development at SK Pharmteco since 2023. Prior to that, they served as the Director, Business Development at Axplora from 2019 to 2023. Richard also worked as the Senior Director Business Development at Rohner Inc. from 2018 to 2019. From 2009 to 2017, they were the Director Business Development at Siegfried (USA), where they successfully established and grew accounts and utilized their pharmaceutical technology knowledge to enhance customer value. Before that, they served as the Director of Business Development at Asymchem Laboratories, focusing on improving customer interaction and increasing business revenues. Richard also held the position of Director, North American Sales at Piramal Healthcare (purchased Avecia), where they brought in projects for different sites. Earlier in their career, they worked at Avecia as a Key Account Manager and at Eastman Chemical Company as a Principal Research Scientist, where they were involved in various technical and development roles.

Richard Fengl, Ph.D. received their Bachelor of Science degree in Chemistry from the College of Charleston. Richard then proceeded to pursue their Ph.D. in Organic Chemistry at Emory University.